Senior Investigator / Chief, NIEHS

Review begins: October 17, 2022

The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), is recruiting for a Senior Investigator to serve as the new Chief of the Epigenetics & Stem Cell Biology Laboratory (ESCBL) https://www.niehs.nih.gov/research/atniehs/labs/escbl/) in the Division of Intramural Research in Research Triangle Park (RTP), NC. RTP is located near Duke University, North Carolina Central University, North Carolina State University, and the University of North Carolina.

The NIEHS is a premier research institute where intramural investigators study a wide range of important biologic questions related to effects of the environment on human health. ESCBL is composed of eight independent research groups that study fundamental mechanisms by which genomic and epigenomic mechanisms influence chromatin architecture, transcription, RNA biology, and gene expression in normal, cancer and embryonic stem cells to provide novel insights into biological processes and environmental diseases. The ESCBL also contains two core facilities that provide DNA sequencing and mass spectrometry support to all the NIEHS.

Qualifications:
The ideal candidate will have an outstanding academic record of achievement, leadership capabilities, and broad interests in transcriptional regulation, epigenetics, chromatin architecture, RNA biology, and stem cell biology. In addition to directing his/her own independent research program, the Chief will be responsible for leading ESCBL and providing vision and directions as research in transcriptional regulation and environmental health science continue to evolve. Principal investigators in the NIH intramural program have no formal teaching duties, are funded internally with ‘hard money’ support, and work with a great deal of protected time. They engage directly in high risk/high reward research with postdoctoral fellows, students, and support staff, and collaborate with colleagues to solve important scientific problems. Applicants should have a PhD, MD, or equivalent doctoral degree in a related field and a demonstrated interest in genomic and epigenomic regulation of gene transcription, chromatin architecture, and/or molecular basis of self-renewal and pluripotency in embryonic stem and cancer cells.

Salary/Benefits:
The successful candidate for this position will be eligible for a tenured appointment and will receive a salary commensurate with experience and accomplishments. The successful candidate will receive full Federal benefits, including leave, health and life insurance, retirement, and savings plan (401K equivalent).

How to Apply:
Review of applications will begin on October 17, 2022. Interested candidates should submit materials as one combined PDF via email to Bonnie Earnhardt at int-appls@niehs.nih.gov. All emails should include vacancy number AC1536 in the subject line.

A complete application package must include:

  • Curriculum Vitae: Include the full curriculum vitae including bibliography. Please include a description of mentoring, commitment to diversity, and outreach activities including any specific outcomes, especially those involving women and persons from other groups which are underrepresented in biomedical research
  • Two-page Statement of Past Research and Future Plans.

In addition, you must arrange for three letters of reference to be sent directly to int-appls@niehs.nih.gov. Letters should be on official letterhead when possible and signed. Referees must include the applicant’s name and vacancy number AC1536 in the email subject line.

Incomplete or paper applications will not be accepted or evaluated.

For further information about the position, please contact Dr. Anton Jetten at jetten@nih.gov. Incomplete applications or paper applications will not be accepted. Review of applications will begin on October 17, 2022, and the search will be closed once the position is filled.

Commitment to Diversity and Equal Employment Opportunity: The NIH NIEHS encourages the application and nomination of qualified women, minorities, and individuals with disabilities. The United States Government prohibits discrimination in employment on the basis of race, color, religion, sex (including pregnancy and gender identity), national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, membership in an employee organization, retaliation, parental status, military service, or other non-merit factors. NIH NIEHS will provide reasonable accommodations to applicants with disabilities as appropriate. If you require reasonable accommodation during any part of the application and hiring process, please notify us.

Foreign Education:
Applicants who have completed part or all of their education outside of the U.S. must have their foreign education evaluated by an accredited organization to ensure that the foreign education is equivalent to education received in accredited educational institutions in the United States. We will only accept the completed foreign education evaluation. For more information on foreign education verification, visit the National Association of Credential Evaluation Services (NACES) website. Verification must be received prior to the effective date of the appointment.

Reasonable Accommodation:
NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis

The NIH is the premier biomedical research center for the world. Its 27 institutes and centers employ more than 18,000 employees doing a vast array of jobs, all supporting efforts for a healthy nation. For information about the NIH mission, goals and institutes and centers, visit https://www.nih.gov/about-nih.

DO NOT INCLUDE YOUR BIRTH DATE OR SOCIAL SECURITY NUMBER (SSN) ON APPLICATION MATERIALS.

DHHS AND NIH ARE EQUAL OPPORTUNITY EMPLOYERS.

This page was last updated on Tuesday, August 23, 2022